A smaller ultrasound instrument needs more than a smaller transducer. MaxQ Medical’s collaboration with Fraunhofer IPMS offers a useful look at how micromachined acoustic components, manufacturing processes and system integration can be developed together.
What did the new partnership introduce?
In its 14 October 2026 announcement, Fraunhofer IPMS describes developing miniaturized ultrasonic transducers for MaxQ Medical. The intended system brings imaging and therapeutic functions into a transurethral instrument, with benign prostatic hyperplasia as the initial application.
The engineering contribution spans transducer design, fabrication-process development, component production, characterization and integration. The news is an application-specific collaboration—not the invention of CMUT itself. For probe developers, its significance is the connection between an acoustic design and the practical constraints of the instrument carrying it.
CMUT, in a few sentences
A capacitive micromachined ultrasonic transducer uses a movable membrane electrode above a fixed electrode. Electrical excitation moves the membrane to generate ultrasound; incoming sound changes the membrane position and capacitance. Many cells can be organized into arrays. Fraunhofer ENAS describes this MEMS architecture as a combination of electrostatic, mechanical and acoustic design.
This is a different route from conventional bulk piezoelectric assemblies. It makes array geometry and electronics interfaces central design choices, rather than establishing that every CMUT instrument will be smaller, cooler or less expensive.
The manufacturing capability behind the collaboration
Fraunhofer IPMS’s general CMUT offering describes a route from concept and prototypes to pilot production, supported by a 200 mm cleanroom, wafer-level testing and material analysis. It also describes a process module for combining CMUT structures with CMOS electronics.
Those are the institute’s broader manufacturing capabilities. They should not be read as disclosed specifications for MaxQ’s particular wafer size, electronics stack, channel count or production yield. The relevant capability is access to a development route that includes fabrication and measurement, not only a design file.
Company context—and the dates that matter
MaxQ is based in Sunnyvale, California, and is the first spinout of Orchard Ultrasound Innovation. Its company-issued 20 August 2026 announcement reported a $31.5 million Series A financing. That financing date is separate from the October partnership announcement.
The August release described the MaxQ system as investigational and unavailable for commercial use in the United States. This article reports a development program, not a purchasing offer, clinical recommendation or regulatory-clearance announcement.
AZNO engineering perspective: what to watch next
For a custom-probe project, a useful brief starts with the instrument’s space envelope, acoustic targets, electrical interfaces, packaging and verification plan. The transducer architecture is one part of that brief.
Our watchlist for this collaboration is practical: packaged-array measurements, imaging and therapeutic operating requirements, electronics integration, application-specific testing and manufacturing qualification. These are AZNO’s questions for following the program—not a company-announced delivery schedule.
The broader lesson is that a manufacturing partner can help carry an ultrasound concept across several engineering boundaries. We look forward to following MaxQ Medical and Fraunhofer IPMS as that work progresses.
Sources and further reading
- Fraunhofer IPMS: MaxQ Medical transducer-development collaboration, 14 October 2026
- MaxQ Medical company-issued financing and development announcement, 20 August 2026
- Fraunhofer IPMS CMUT manufacturing capabilities
- Fraunhofer ENAS: CMUT operating principles
- Company websites: MaxQ Medical and Fraunhofer IPMS.
AZNO Editorial · AI-assisted research and writing. AZNO has not tested this system and does not claim a commercial relationship with either organization. The outlook above is AZNO engineering commentary. The official wafer and evaluation-kit photographs are not reproduced on this page.